%rebase base nav_tree=nav_tree

<div id="main">

<h2>Taylor et al. - Integrative Genomic Profiling of Human Prostate Cancer</h2>

<p>Taylor et al concordantly assessed DNA copy number, exon expression and miRNA expression in 218 prostate cancer tumors. They identified the nuclear receptor coactivator NCOA2 as an oncogene in 11% of tumors. Additionally, the androgen-driven TMPRSS2-ERG fusion was associated with a previously unrecognized, prostate-specific deletion at chromosome 3p14 that implicates FOXP1, RYBP, and SHQ1 as potential cooperative tumor suppressors.</p>
		
<h3>Gene-level views</h3><ul>
	<li><a href="/prostate_cancer/taylor/gene_boxplot">Expression box plot</a></li>
	<li><a href="/prostate_cancer/taylor/feature_matrix">Feature matrix</a></li>
	<li><a href="/prostate_cancer/taylor/gene_survival">Kaplan-Meier survival plot</a></li>
	<li><a href="/prostate_cancer/taylor/parallel_coordinates">Parallel coordinates</a></li>
</ul>

<h3>Alternative splicing</h3><ul>
<li><a href="/prostate_cancer/taylor/alt_splicing">Alternative splicing boxplot (gene)</a></li>
<li><a href="/prostate_cancer/taylor/alt_splicing_exon">Alternative splicing boxplot (single exon)</a></li>
<li><a href="/prostate_cancer/taylor/alt_splicing_survival">Alternative splicing survival association</a></li>
<li><a href="/prostate_cancer/taylor/alt_splicing_toplist">Alternative splicing toplists</a></li>
</ul>


<h3>Copy number tracks</h3><ul>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_all.seg">All tumors, paired with adjacent normal or universal reference</a></li>
</ul>

<h3>Recurrence tracks</h3><ul>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_all_recurrence.igv">All tumors, paired with adjacent normal or universal reference</a></li>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_primary_recurrence.igv">Primary tumors, paired with adjacent normal or universal reference</a></li>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_metastatic_recurrence.igv">Metastatic tumors, paired with adjacent normal or universal reference</a></li>
</ul>

<h3>Significance tracks</h3><ul>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_all_significance.igv">All tumors, paired with adjacent normal or universal reference</a></li>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_primary_significance.igv">Primary tumors, paired with adjacent normal or universal reference</a></li>
	<li><a href="http://www.broadinstitute.org/igv/dynsession/igv.jnlp?sessionURL=http://viherjora.cs.tut.fi/betadata/taylor_pca_metastatic_significance.igv">Metastatic tumors, paired with adjacent normal or universal reference</a></li>
</ul>

</div>

<div id="sidebar">
<div class="sidebox">
<p><b>Dataset overview</b><br />
Last update: 21-03-2011<br />
Total samples: 218<br />
Total patients: 218<br />
</p>
	
<p><b>Platforms used</b><br>
<a href="/microarrays/affy_huex">Affymetrix Human Exon 1.0 ST</a><br>
Agilent HG CGH 244A<br>
Agilent miRNA 8x15K v2.0<br>
</p>

</ul></div></div>

